These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31295022)

  • 1. JNK1 regulates RANKL-induced osteoclastogenesis
    Ke D; Ji L; Wang Y; Fu X; Chen J; Wang F; Zhao D; Xue Y; Lan X; Hou J
    FASEB J; 2019 Oct; 33(10):11082-11095. PubMed ID: 31295022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy mediated by JNK1 resists apoptosis through TRAF3 degradation in osteoclastogenesis.
    Ke D; Zhu Y; Zheng W; Fu X; Chen J; Han J
    Biochimie; 2019 Dec; 167():217-227. PubMed ID: 31654668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin suppresses RANKL-induced osteoclast precursor autophagy in osteoclastogenesis by inhibiting RANK signaling and downstream JNK-BCL2-Beclin1 pathway.
    Ke D; Xu H; Han J; Dai H; Wang X; Luo J; Yu Y; Xu J
    Biomed J; 2024 Feb; 47(1):100605. PubMed ID: 37179010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis.
    Ke D; Yu Y; Li C; Han J; Xu J
    Mol Med; 2022 Feb; 28(1):22. PubMed ID: 35183115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17A regulates the autophagic activity of osteoclast precursors through RANKL-JNK1 signaling during osteoclastogenesis in vitro.
    Ke D; Fu X; Xue Y; Wu H; Zhang Y; Chen X; Hou J
    Biochem Biophys Res Commun; 2018 Mar; 497(3):890-896. PubMed ID: 29476739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17A inhibits the degradation of RANKL in osteoblasts by inhibiting BCL2-Beclin1-autophagy signaling.
    Chen XX; Wu HJ; Ke DS; Zhu YR
    In Vitro Cell Dev Biol Anim; 2023 Apr; 59(4):300-311. PubMed ID: 37002492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17A modulates osteoclast precursors' apoptosis through autophagy-TRAF3 signaling during osteoclastogenesis.
    Xue Y; Liang Z; Fu X; Wang T; Xie Q; Ke D
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1088-1092. PubMed ID: 30553450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and -independent autophagic responses.
    Zhang G; Wang Y; Tang G; Ma Y
    BMC Complement Altern Med; 2019 Oct; 19(1):269. PubMed ID: 31615565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rubiadin-1-methyl ether inhibits BECN1 transcription and Beclin1-dependent autophagy during osteoclastogenesis by inhibiting NF-κB p65 activation.
    Cai S; Chen Y; Chen J; Wei W; Pan J; Wu H
    Exp Biol Med (Maywood); 2023 Sep; 248(17):1518-1526. PubMed ID: 37750211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-17 promotes osteoclastogenesis and periodontal damage via autophagy in vitro and in vivo.
    Zhong J; Wang Z; Yuan W; Shen Y; Chen L
    Int Immunopharmacol; 2022 Jun; 107():108631. PubMed ID: 35219162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulforaphane Inhibits Osteoclastogenesis via Suppression of the Autophagic Pathway.
    Luo T; Fu X; Liu Y; Ji Y; Shang Z
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33445451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
    J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17A regulates autophagy and promotes osteoclast differentiation through the ERK/mTOR/Beclin1 pathway.
    Tang H; Zhu S; Chen K; Yuan S; Hu J; Wang H
    PLoS One; 2023; 18(2):e0281845. PubMed ID: 36795736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
    Yang J; Park OJ; Lee YJ; Jung HM; Woo KM; Choi Y
    Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-osteoclastogenic activity of isoliquiritigenin via inhibition of NF-κB-dependent autophagic pathway.
    Liu S; Zhu L; Zhang J; Yu J; Cheng X; Peng B
    Biochem Pharmacol; 2016 Apr; 106():82-93. PubMed ID: 26947453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1α,25-(OH)
    Yu C; Zhu Y; Lv X; Wang Y
    In Vitro Cell Dev Biol Anim; 2021 Oct; 57(9):878-885. PubMed ID: 34780049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrogen-activated autophagy has a negative effect on the anti-osteoclastogenic function of oestrogen.
    Cheng L; Zhu Y; Ke D; Xie D
    Cell Prolif; 2020 Apr; 53(4):e12789. PubMed ID: 32157750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.